522 related articles for article (PubMed ID: 16216010)
1. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Bauvois B; Dauzonne D
Med Res Rev; 2006 Jan; 26(1):88-130. PubMed ID: 16216010
[TBL] [Abstract][Full Text] [Related]
2. Aminopeptidase N (CD13) as a target for cancer chemotherapy.
Wickström M; Larsson R; Nygren P; Gullbo J
Cancer Sci; 2011 Mar; 102(3):501-8. PubMed ID: 21205077
[TBL] [Abstract][Full Text] [Related]
3. The structure and main functions of aminopeptidase N.
Luan Y; Xu W
Curr Med Chem; 2007; 14(6):639-47. PubMed ID: 17346152
[TBL] [Abstract][Full Text] [Related]
4. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Park HJ; Shim BS; Choi SH; Kwon HJ
Chem Biol; 2003 Aug; 10(8):695-704. PubMed ID: 12954328
[TBL] [Abstract][Full Text] [Related]
5. Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Cao J; Ma C; Zang J; Gao S; Gao Q; Kong X; Yan Y; Liang X; Ding Q; Zhao C; Wang B; Xu W; Zhang Y
Bioorg Med Chem; 2018 Jul; 26(12):3145-3157. PubMed ID: 29859750
[TBL] [Abstract][Full Text] [Related]
6. Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.
Lendeckel U; Wex T; Reinhold D; Kähne T; Frank K; Faust J; Neubert K; Ansorge S
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):817-21. PubMed ID: 8920985
[TBL] [Abstract][Full Text] [Related]
7. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
8. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
[TBL] [Abstract][Full Text] [Related]
9. Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.
Amin SA; Adhikari N; Jha T
J Med Chem; 2018 Aug; 61(15):6468-6490. PubMed ID: 29630364
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and 4D-QSAR Studies of Alanine Hydroxamic Acid Derivatives as Aminopeptidase N Inhibitors.
Gao M; Lv Q; Zhang H; Tu G
Med Chem; 2021; 17(6):658-666. PubMed ID: 31880250
[TBL] [Abstract][Full Text] [Related]
11. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells.
Kwon HJ; Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Yu J
Jpn J Cancer Res; 2002 Apr; 93(4):417-25. PubMed ID: 11985792
[TBL] [Abstract][Full Text] [Related]
12. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini R; Koivunen E; Kain R; Lahdenranta J; Sakamoto M; Stryhn A; Ashmun RA; Shapiro LH; Arap W; Ruoslahti E
Cancer Res; 2000 Feb; 60(3):722-7. PubMed ID: 10676659
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic activity is not a precondition for the intracellular calcium increase mediated by mAbs specific for aminopeptidase N/CD13.
Navarrete Santos A; Langner J; Riemann D
Adv Exp Med Biol; 2000; 477():43-7. PubMed ID: 10849729
[No Abstract] [Full Text] [Related]
14. Novel small molecule nonpeptide aminopeptidase n inhibitors with a cyclic imide skeleton.
Shimazawa R; Takayama H; Fujimoto Y; Komoda M; Dodo K; Yamasaki R; Shirai R; Koiso Y; Miyata K; Kato F; Kato M; Miyachi H; Hashimoto Y
J Enzyme Inhib; 1999; 14(4):259-75. PubMed ID: 10445048
[TBL] [Abstract][Full Text] [Related]
15. Betulinic acid inhibits aminopeptidase N activity.
Melzig MF; Bormann H
Planta Med; 1998 Oct; 64(7):655-7. PubMed ID: 9810272
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors.
Yang K; Wang Q; Su L; Fang H; Wang X; Gong J; Wang B; Xu W
Bioorg Med Chem; 2009 Jun; 17(11):3810-7. PubMed ID: 19423354
[TBL] [Abstract][Full Text] [Related]
17. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
[TBL] [Abstract][Full Text] [Related]
18. Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro.
Shim JS; Lee HS; Shin J; Kwon HJ
Cancer Lett; 2004 Jan; 203(2):163-9. PubMed ID: 14732224
[TBL] [Abstract][Full Text] [Related]
19. Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.
Piedfer M; Dauzonne D; Tang R; N'Guyen J; Billard C; Bauvois B
FASEB J; 2011 Aug; 25(8):2831-42. PubMed ID: 21566207
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]